COVIDIEN $65.17

down -0.04


24/5/2013 04:24 PM  |  NYSE : COV  |  Industries : Manufacturing / Medical Equipment and Supplies Manufacturing
12 Mo. Price Change : 22% - COV has underperformed the S&P 500 by 3%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Covidien Announces Continued Relationship with NYSE Euronext

    Benzinga

  2. Covidien Files Form 10 Registration Statement in Connection with ...

    Benzinga

  3. UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Covidien plc

    Benzinga

  4. UPDATE: Goldman Sachs Reiterates Neutral Rating, Raises PT on ...

    Benzinga

  5. Covidien profit tops estimates

    Investors Business Daily

  6. A Peek Into The Market Before The Trading Starts

    Benzinga

  7. UPDATE: Covidien Raises FY13 Sales-Growth Forecast

    Benzinga

  8. US Stock Futures Higher Ahead Of P&G Earnings, New Home Sales Data

    Benzinga

  9. Earnings Scheduled For January 25, 2013

    Benzinga

  10. Earnings Expectations for the Week of January 21

    Benzinga

  11. My 4 Favorites from the 20 Most Recommended Dividend Stocks at ...

    GuruFocus

  12. Covidien Launches OneShot Renal Denervation System

    Benzinga

  13. Covidien Announces Enrollment of First Patient in SWIFT PRIME ...

    Benzinga

  14. The 3 Most-Recommended Healthcare Stocks

    GuruFocus

  15. UPDATE: Goldman Sachs Reiterates Neutral Rating, Raises PT on ...

    Benzinga

  16. Mallinckrodt Launches Generic Version of CONCERTA in U.S.

    Benzinga

  17. Covidien to buy CV Ingenuity

    Investors Business Daily

  18. A Peek Into The Market Before The Trading Starts

    Benzinga

  19. Covidien to Acquire CV Ingenuity

    Benzinga

  20. Surprisingly, Politicians Could Boost Medical Device ETFs

    Benzinga

  21. Paulson Says Bet Against Europe to Blame for Down Year, Slashed EU ...

    GuruFocus

  22. Covidien Launches Meniscal Repair Device

    Benzinga

  23. Covidien Ltd. Reports Operating Results (10-K)

    GuruFocus

  24. Top 4 Large-Cap Stocks In The Medical Instruments & Supplies ...

    Benzinga

  25. Covidien EPS falls, still beats

    Investors Business Daily

  26. Covidien Stock Rises After Earnings Beat Estimates

    Investors Business Daily

  27. UPDATE: Covidien FQ4 Net Profit Rises 2.2%

    Benzinga

  28. Top 4 Large-Cap Stocks In The Medical Instruments & Supplies ...

    Benzinga

  29. Edwards, Other Medical Stocks Dip In Sync With Market

    Investors Business Daily

  30. GuruFocus.com Interview with Steve Romick, Portfolio Manager of ...

    GuruFocus

  31. From Earlier: Covidien Announces FDA 510k Clearance and CE Mark ...

    Benzinga

  32. The Best Stocks With Dividend Growth From Last Week (September 24 ...

    GuruFocus

  33. Covidien to buy CNS

    Investors Business Daily

  34. 12 Dividend Challengers With Huge Potential To Become A Dividend Hero

    GuruFocus

  35. UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on ...

    Benzinga

  36. UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Covidien

    Benzinga

  37. Covidien Guides FY13 Pharma Sales Up 1-4%, 2013 Sales Up 3-6%

    Benzinga

  38. UPDATE: Covidien to Shutter South Carolina Plant, Lay Off 595 -Reuters

    Benzinga

  39. Mallinckrodt Announces Agreement with Xanodyne to Purchase Roxicodone

    Benzinga

  40. Covidien slips on recall

    Investors Business Daily

  41. Covidien Stock Dips As Product Recall Nips Guidance

    Investors Business Daily

  42. Covidien Ltd. Reports Operating Results (10-Q)

    GuruFocus

  43. Stocks Futures Higher Ahead of Jobs Data with Facebook (FB) and ...

    At Market Intelligence Center

  44. UPDATE: Covidien FQ3 Net Profit Drops 15%

    Benzinga

  45. Earnings Scheduled For July 26

    Benzinga

  46. Ultimate Stock Watch List for The Supreme Court's Health Care Ruling

    Benzinga

  47. Steven Romick's Top Stock Picks

    GuruFocus

  48. Microsoft, FedEx Among Stocks Up on High Volume Tuesday

    FOXBusiness

  49. Internet Wealth Builder Updates on COV, DEO, TEF, SAN

    GuruFocus

  50. Covidien (COV) Sees Over 3x Average Number of Puts Trade with ...

    At Market Intelligence Center

  51. Covidien Announces Pricing of $1.250 Billion Senior Notes Offering

    Benzinga

  52. UPDATE: J.P. Morgan Raises Covidien's PT

    Benzinga

  53. Covidien (COV) Down 0.7% on Earnings Miss, Sees 3x Average Option ...

    At Market Intelligence Center

  54. Covidien To Buy Oridion In Latest Device Acquisition

    at IBD

  55. Covidien (COV) Up 0.4% on FDA Approval, Sees 3x Average Put Volume

    At Market Intelligence Center

  56. Notable Put Options Activity in Covidien

    at Benzinga

  57. Financial Breakfast: Morning News Summary for March 5, 2012

    at Benzinga

  58. FPA Crescent Fund Buys Arris Group, Thermo Fisher, Citigroup, ...

    at GuruFocus

  59. The Best Yielding Dividend Stocks Buys From Steven Romick (FPA ...

    at GuruFocus

  60. Covidien Ltd. Reports Operating Results (10-Q)

    at GuruFocus

  61. Hussman Fund Q4 Portfolio Overview

    at GuruFocus

  62. Hercules Technology Growth Capital to Realize Q1 Gain of ...

    at Benzinga

  63. Covidien Revascularization Device Approved for Interventional ...

    at Benzinga

  64. Covidien, Other Irish Medical Names Behave Well

    at IBD

  65. Covidien

    at IBD

  66. 5 Stocks Seeing Big Analyst Downgrades

    at GuruFocus

  67. Covidien (COV) Gains 1.2% As Put-Call Ratio Climbs Above 12

    At Market Intelligence Center

  68. Clinical Data for DURABILITY II Study Presented at ISET 2012; Met ...

    at Benzinga

  69. From Earlier: Covidien Releases Clinical Data on Plaque Excision ...

    at Benzinga

  70. FPA Top Holdings - My fair value analysis

    at GuruFocus

  71. Stocks Futures Point to a Higher Open as European Debt Fears Ease

    At Market Intelligence Center

  72. Goldman Sachs Downgrades Covidien to Neutral

    at Benzinga

  73. COV remains stuck below its stubborn 60-day moving average

    By SchaeffersResearch

  74. Fast Money Picks For December 16th (AET, M, MANT, ETR, COV, LLY, ADBE)

    at Benzinga

  75. Covidien rises on spin-off plan

    at IBD

  76. European Stocks at 52-Week Lows

    at GuruFocus

  77. European Stocks at 52-Week Lows: COV, NOK, TI, RIG

    at GuruFocus

  78. Covidien's Poor Price Action Attracts Bears

    By SchaeffersResearch
People viewing COV also viewed: , , , , , ,
Marketplace
Trading Center